Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical CarePRNewsWire • 08/05/25
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene SequencingPRNewsWire • 07/29/25
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock RisesZacks Investment Research • 07/22/25
Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025PRNewsWire • 07/22/25
DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance?Zacks Investment Research • 07/21/25
Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price TodaySeeking Alpha • 07/15/25
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's DiseasePRNewsWire • 07/09/25
Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?Zacks Investment Research • 07/07/25
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health SpaceZacks Investment Research • 07/02/25
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025PRNewsWire • 06/23/25
Quest Diagnostics Stock Trades Near A Buy Zone; Capture Profits With This Long Call Butterfly In Options TradingInvestors Business Daily • 06/20/25
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson TechnologyPRNewsWire • 06/10/25
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?Zacks Investment Research • 05/27/25